Might see further downside. A likely shakeout. Timeframe till November 2021. Position sized according to the risk so no worries. Could see further downside.
FrontPage is India's Stock Market Social Network
Join 50,000+ Traders and Investors
INFIBEAM
45.1
+0.1 (0.22%)
Updated 03:29 28/07 IST
INFIBEAM Buy or Sell - FrontPage Forums
4 Users have submitted 4 trade ideas of Rs. 225,793.5 for INFIBEAM
Disclaimer100% Bullish
0% Bearish
INFIBEAM Buy or Sell - Brokerage Reports
No. of reports in last year
1
No. of analysts
1
Average Consensus Forecast
105
Consensus Potential
57.14%
INFIBEAM Ratings
Long term INFIBEAM rating by FrontPage users
- ★★
- ★★
- ★★
- ★★
- ★★
0/5 (0 Ratings)0
Find answers to all your questions on live INFIBEAM message board: Is INFIBEAM buy or sell? Should I buy INFIBEAM shares? Why are INFIBEAM shares falling? Should I invest in INFIBEAM stock?
- Home
- INFIBEAM Forum
INFIBEAM Share Price Discussion
S
Reputation: 75 • Jul 23 6:54 AM
#INFIBEAM why it keeps falling further already down by 7 %today ...any insight ????
Like
Reply
T
Reputation: 1,467 • Jul 9 4:01 AM
Dr K in INFIBEAM#INFIBEAM a well established player in the dig...
#INFIBEAM has some good accumulation around the 50-52 levels if you do a study on it. Timeframe till November when the integration should be completed with Jiomart and the NUE application should get sorted by then.
#InvestmentIdeas #InvestingUniversity
1
Reply (12)
See all replies
@ssp-Hk_nZjt6d no idea! Might be a shakeout. An insider selling too. My average is still below the CMP. Just leaving it in for the long term. Position sized according to the risk so no worries.
@thetradedoctor thank you sir ....esop share was allotted may be because of this it can be i feel
@thetradedoctor ravi agarwal sold 7,176,818 of shares in infibeam avenue that is a reason but not sure if any bad news is there
T
Reputation: 1,467 • Jun 23 8:33 AM
#INFIBEAM had posted it yesterday. More than 15% up intraday and has pulled back now. Still a good 5% up.
Like
Reply
N
Reputation: 15,707 • Jun 23 6:56 AM
Infibeam, Godrej Agrovet among 42 stocks set of rally, suggests MACD
The list included mostly mid and smallcap names such as Infibeam Avenues, Bharat Electronics, Texmaco Rail and Godrej Agrovet. These stocks are up 7-12 per cent in Wednesday's trade.
The list included mostly mid and smallcap names such as Infibeam Avenues, Bharat Electronics, Texmaco Rail and Godrej Agrovet. These stocks are up 7-12 per cent in Wednesday's trade.
The Economic Times
Like
Reply
T
Reputation: 1,467 • Jun 22 6:00 AM
#INFIBEAM timeframe 3-6 months. Wait for further price action or enter with a strict SL.
Like
Reply
Join FrontPage
FrontPage is India's favorite stock discussions community
Join 2,00,000 Indian traders and discuss trades, strategies, news & views on any stock.
- keyboard_arrow_down
INFIBEAM Share Price - Technicals
- NewsBotJun 3 10:01 AM
RemitGuru operator Fable Fintech gets funding from Paytm, Infibeam and othersThe Economic TimesNewsBotMay 27 3:36 AM
Infibeam Avenues Q4 results: Reports net profit of Rs 32 crThe Economic TimesNewsBotMay 27 2:16 AM
Infibeam Avenues subsidiary GoPayments to foray into neobankingThe Economic TimesNewsBotMay 27 12:16 PM
Infibeam says it has signed definitive agreement with Reliance Industries’ Jio Platforms, have applied for NUEThe Economic TimesNewsBotMay 12 11:36 AM
RemitGuru to raise $50 million from a group of investors including Paytm, InfibeamThe Economic TimesNewsBotMar 10 3:21 AM
DRC System, a merged entity of Infibeam hits BSE and NSE todayThe Economic TimesNewsBotFeb 27 11:31 AM
Reliance partners Google, Facebook in seeking NUE licence from RBIThe Economic TimesNewsBotFeb 14 5:38 AM
Infibeam Avenues Q3 Net Profit Up 27% To Rs 14.99 Crore; Announces 1:1 Bonus Share IssueMoneycontrolNewsBotFeb 12 5:36 AM
Infibeam Q3 Results: Net profit up 27%; firm announces 1:1 bonus share issueThe Economic TimesNewsBotFeb 11 2:21 AM
Infibeam to apply for apply for RBI’s New Umbrella Entity licenseThe Economic Times
SOURCE: Data from D'Market via Quandl. Intraday data delayed 15 minutes.
DISCLAIMER: Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and FrontPage will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein.